|Bid||2.0300 x 3100|
|Ask||2.2500 x 1800|
|Day's Range||2.0350 - 2.1000|
|52 Week Range||1.7000 - 5.9300|
|Beta (5Y Monthly)||1.86|
|PE Ratio (TTM)||41.00|
|Earnings Date||Apr 25, 2022 - Apr 29, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.83|
Accuray Incorporated (NASDAQ: ARAY) announced today that Seth Blacksburg, M.D., MBA has joined the company as vice president, chief medical officer for the Americas (North and South America) region. Dr. Blacksburg will be responsible for bringing the strategic clinical insights, real-world experience and voice of the customer necessary to help drive the continued commercial growth of the region. He will report to Mike Leischer, Accuray president and general manager for the Americas region.
Accuray (ARAY) partners with Genolier Innovation Hub to unite companies from the MedTech, pharma and biosciences sectors with physicians and scientists for better patient outcomes.
Accuray Incorporated (NASDAQ: ARAY) announced today the company is joining forces with Genolier Innovation Hub, a fully-owned subsidiary of AEVIS VICTORIA SA (SWX: AEVS), in support of a unique new approach to improving patient care. Genolier Innovation Hub will unite companies from the medtech, pharma and biosciences sectors, physicians and scientists, under one roof, with the goal of bringing medical and technological advances to patients faster. The Hub is expected to open in early 2024.